Drugs / SJ04
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06599528 | Aug 2024 → Jun 2026 overdue | female infertility | Suzhou Centergene Pharmaceuticals Co.,Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SJ04 | “SJ04 is a biosimilar of Ovidrel® and is highly similar to Ovidrel®.” NCT06599528 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human chorionic gonadotropin injection (SJ04)” NCT06599528 ↗ |